Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 17, Number 11—November 2011


Congenital Syphilis, Réunion Island, 2010

Juliana Ramiandrisoa, Lydéric Aubert, Emilie Boidin Lespine, Jean-Luc Alessandri, Pierre-Yves Robillard, Marc Bertsch, Anne Gallay, Véronique Goulet, and Eric D’OrtenzioComments to Author 
Author affiliations: Regional Office of French Institute for Public Health Surveillance in the Indian Ocean, Saint-Denis, Réunion Island, France (J. Ramiandrisoa, L. Aubert, E.B. Lespine, E. D’Ortenzio); Regional Hospital, Saint-Denis (J.-L. Alessandri, P.-Y. Robillard); Centre Hospitalier Gabriel Martin, Saint-Paul, Réunion Island (M. Bertsch); French Institute for Public Health Surveillance, Saint-Maurice, France (A. Gallay, V. Goulet)

Main Article


Clinical and biological characteristics of mothers and children with congenital syphilis, Réunion Island, 2010*

Year of diagnosis Mother

Age, y Time of syphilis screening Duration of treatment, d Presence andsatage of disease Positive serologic titer test results Gestation, wk Clinical signs
2008 16 >13 wk gestation 5 d BD Probable secondary syphilis at first trimester TPHA, VDRL, FTA-ABS 34 None
2008 25 Unknown 2 d AD NA TPHA, VDRL, FTA-ABS 34 None
2008 16 AD 14 d AD Primary syphilis at third trimester TPHA, VDRL, FTA-ABS 38 None
2009 26 >13 wk gestation 17 d BD NA TPHA, VDRL, FTA-ABS 31 Present
2009 18 >13 wk gestation 2 d BD NA TPHA, VDRL 32 Present
2009 22 >13 wk gestation 1 d BD NA TPHA, VDRL 32 Present
2009 37 After delivery 1 d AD NA TPHA, VDRL 38 None

*BD, before delivery; TPHA, Treponema pallidum hemagglutination assay; VDRL, Venereal Disease Research Laboratory; FTA-ABS, fluorescent treponemal antibody absorption; AD, after delivery; NA, not applicable.

Main Article